温馨提示：本站仅提供公开网络链接索引服务，不存储、不篡改任何第三方内容，所有内容版权归原作者所有
AI智能索引来源：http://www.ft.com/genomics
点击访问原文链接

Genomics | Financial Times

进入原网站 导航首页
Accessibility helpSign InSubscribeFinancial TimesSubscribeSign InHomeWorldWorld HomeMiddle East warGlobal EconomyUKUSChinaAfricaAsia PacificEmerging MarketsEuropeWar in UkraineAmericasMiddle East & North AfricaKharg Island: Iran’s oil lifeline that Trump has left untouchedTrump’s Venezuela strategy has failed in IranWhich economies will pay the biggest price for the Iran war?Farage misses out on Trump meeting as their relationship coolsG7 discuss joint release of emergency oil reservesUSUS HomeUS EconomyUS CompaniesUS Politics & PolicyKharg Island: Iran’s oil lifeline that Trump has left untouchedTrump’s Venezuela strategy has failed in IranWhich economies will pay the biggest price for the Iran war?Farage misses out on Trump meeting as their relationship coolsIran war will leave a complex geoeconomic legacyCompaniesCompanies HomeEnergyFinancialsHealthIndustrialsMediaProfessional ServicesRetail & ConsumerTech SectorTelecomsTransportKharg Island: Iran’s oil lifeline that Trump has left untouchedWhich economies will pay the biggest price for the Iran war?G7 discuss joint release of emergency oil reservesEx-EY executive launches private equity-backed tax firm to challenge Big FourPimco sticks with bet on gilts despite market slumpTechTech HomeArtificial intelligenceSemiconductorsCyber SecuritySocial MediaSheryl Sandberg and Nick Clegg join Nvidia-backed AI start-up NscaleKKR eyes multibillion-dollar sale of data centre cooling companyAnthropic sues the Pentagon over being declared a ‘supply chain risk’Is South Korea’s dominant online retailer an American company?Microsoft adds Anthropic AI models to its Copilot workplace toolsMarketsMarkets HomeAlphavilleMarkets DataCryptoCapital MarketsCommoditiesCurrenciesEquitiesMonetary Policy RadarWealth ManagementMoral MoneyETF HubFund ManagementTradingKharg Island: Iran’s oil lifeline that Trump has left untouchedWhich economies will pay the biggest price for the Iran war?G7 discuss joint release of emergency oil reservesIran war will leave a complex geoeconomic legacyPimco sticks with bet on gilts despite market slumpClimateOpinionOpinion HomeColumnistsThe FT ViewThe Big ReadLexObituariesLettersTrump’s Venezuela strategy has failed in IranIran war will leave a complex geoeconomic legacyAmerica chose this war — and must now choose how to end itStagflationary forces are buildingWhy it’s time to end the grim march of the touchscreenLexWork & CareersWork & Careers HomeBusiness School RankingsBusiness EducationEurope's Start-Up HubsEntrepreneurshipRecruitmentBusiness BooksBusiness TravelWorking ItWhy it’s time to end the grim march of the touchscreenYou can turn this to your advantage if every news story has ‘tax exile’ in itBusiness school professors’ picksLife & ArtsLife & Arts HomeArtsBooksFood & DrinkFT MagazineHouse & HomeStylePuzzlesTravelFT GlobetrotterHow to wear a tie: HTSI’s definitive guideWine storage is emerging from the cellarFlip it and reverse it: the enduring fun of Jaeger-LeCoultre’s Reverso A whirlwind guide to Washington’s Library of Congress‘Match of the century’ referee Lothar Schmid’s chess library up for auctionHow To Spend ItHomeWorldUSCompaniesTechMarketsClimateOpinionLexWork & CareersLife & ArtsHow To Spend ItFinancial TimesSubscribeSign InScience booksOn the Future of Species — unnatural selectionGeneticist and entrepreneur Adrian Woolfson argues that genome engineering and AI will let us design organisms beyond nature’s limitsLife & ArtsFT Magazine. They clone polo ponies, don’t they?Meet the minds behind the sport’s next (and peculiar) high-tech gambleNeurotechnologyCats give genetic clues to better cancer treatmentsSimilarities between pet and human tumours suggest new ideas for targeting bothMedical scienceScientists link 22 genes to deadly risks from common virusResearch probes persistence of Epstein-Barr virus that can cause serious illnesses, including cancersUS companiesNvidia and Microsoft back AI breakthrough for gene therapiesUK’s Basecamp Research uses species genomic sequence database to tackle cancers and superbugsAgritechBayer’s ambitions boosted by relaxation of EU gene-edited crop rulesGerman life sciences giant says looser regulations could reshape Europe’s €6bn seed marketLife & ArtsFT Magazine. Jailed for gene-editing, a notorious scientist is not done yetHe Jiankui’s experiment with human embryos caused global outrage. Can he make an unlikely comeback?NeurotechnologyLab-grown genomes set to transform human DNAResearch shows synthetic chromosomes can be transferred to human cells with potential to improve viral resistanceAgricultural productionBrussels backs softer regime for gene-edited plantsAgreement over lighter-touch regulation marks first big loosening of rules since ‘Frankenfoods’ outcry 20 years agoArtificial intelligenceNew AI model enhances diagnosis of rare diseasesPopEVE system outperformed rivals such as Google DeepMind’s AlphaMissenseJames WatsonObituary. James Watson, co-discoverer of DNA’s double helix, dies aged 97US biochemist was responsible with the UK’s Francis Crick for 20th century’s most important biological discoveryMedical scienceScientists unveil pigs gene-edited to resist swine fever‘Genetic scissors’ technology could boost efforts to protect millions of animals from diseaseArtificial intelligenceNew AI model predicts susceptibility to over 1,000 diseasesEuropean scientists have created system trained on large-scale health recordsScienceGenetic engineering and the fight for the soul of conservationThe scale of the biodiversity crisis means we cannot ignore the potential of technologyAnjana AhujaDisease control and preventionLandmark DNA study charts blood ageing caused by cancer drugsResearch offers clues to choosing chemotherapy treatments with fewer long-term side effectsFishing industryThe incredible shrinking fish: how evolution of Baltic cod helps them dodge netsGenetic shift driven by over-exploitation risks undermining populations beyond repair, according to researchMedical scienceCuriosity underlies a breakthrough in rare diseaseWe must recognise and protect the pipelines that lead from research to real-world benefitAnjana AhujaDrugs researchScientists give pioneering gene therapy to infant patientChild suffering from rare liver disease shows improved health after treatmentScientific researchThe ‘dire wolf’ dilemmaThere’s clever technology behind the de-extinction of species but it may have undesired consequencesHenry MancePerson in the NewsAnne Wojcicki, the floundering 23andMe’s eternal optimistDespite the company filing for bankruptcy, the co-founder won’t give up on her dream of using DNA kits to discover new drugsAbu DhabiAbu Dhabi’s quest to turn its DNA ‘gold mine’ into big businessProject backed by national security chief Sheikh Tahnoon aims to commercialise mammoth Emirati genetic databaseThe Future of Digital HealthcareProtein project uses AI to boost disease treatmentUK initiative to harness big biological data sets and look deeper into how the human body works and malfunctionsScientific researchStart-up says its ‘woolly mice’ bring mammoth revival closerScientists warn big obstacles, including ethical questions, remain in efforts to restore extinct speciesHealthGene screening can cut early disease deaths by 25%, study showsPeople prone to breast cancer and diabetes among beneficiaries of early testingLife & ArtsFT Magazine. We are a bit NeanderthalWhat modern genetics has taught us about human historySimon KuperHelp CentreContact UsAbout UsAccessibilityCareersSuppliersTerms & ConditionsPrivacy PolicyCookie PolicyManage CookiesCopyrightSlavery Statement & PoliciesShare News Tips SecurelyIndividual SubscriptionsProfessional SubscriptionsRepublishingExecutive Job SearchAdvertise with the FTFollow the FT on XFT ChannelsFT SchoolsPortfolioFT AppFT Digital EditionFT EditAlerts HubBusiness School RankingsSubscription ManagerNews feedNewslettersCurrency ConverterFT Live EventsFT ForumsFT Leaders AcademyMore from the FT GroupFT Editorial Code of PracticeUKSubscribe for full accessHomeWorldMiddle East warGlobal EconomyUKUSChinaAfricaAsia PacificEmerging MarketsEuropeWar in UkraineAmericasMiddle East & North AfricaUSUS EconomyUS CompaniesUS Politics & PolicyCompaniesEnergyFinancialsHealthIndustrialsMediaProfessional ServicesRetail & ConsumerTech SectorTelecomsTransportTechArtificial intelligenceSemiconductorsCyber SecuritySocial MediaMarketsAlphavilleMarkets DataCryptoCapital MarketsCommoditiesCurrenciesEquitiesMonetary Policy RadarWealth ManagementMoral MoneyETF HubFund ManagementTradingClimateOpinionColumnistsThe FT ViewThe Big ReadLexObituariesLettersLexWork & CareersBusiness School RankingsBusiness EducationEurope's Start-Up HubsEntrepreneurshipRecruitmentBusiness BooksBusiness TravelWorking ItLife & ArtsArtsBooksFood & DrinkFT MagazineHouse & HomeStylePuzzlesTravelFT GlobetrotterPersonal FinanceProperty & MortgagesInvestmentsPensionsTaxBanking & SavingsAdvice & CommentHow To Spend ItSpecial ReportsAlphavilleFT EditLunch with the FTFT Globetrotter#techAsiaMoral MoneyVisual and data journalismNewslettersVideoPodcastsNews feedFT SchoolsFT Live EventsFT ForumsFT Leaders AcademymyFTPortfolioFT Digital EditionCrosswordOur AppsHelp CentreSubscribeSign In

智能索引记录